EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration

Saagar A Pandit, Bita Momenaei, Taku Wakabayashi, Hana A Mansour, Sudheshna Vemula, Asad F Durrani, Bahram Pashaee, Adina S Kazan, Allen C Ho, Michael Klufas, Carl Regillo, Yoshihiro Yonekawa und 3 weitere

Ophthalmology Retina · 2024-04 · 8 (4) · 360-366

DOI: 10.1016/j.oret.2023.10.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Retina, 2024-04. Verfasst von Saagar A Pandit und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Retina Service of Wills Eye Hospital, Wills Eye Physicians - Mid Atlantic Retina, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Retinal Detachment, Macular Degeneration, Antibodies, Bispecific. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal DetachmentMacular DegenerationAntibodies, BispecificHumansAgedAged, 80 and overRanibizumabAngiogenesis InhibitorsVascular Endothelial Growth Factor ARetrospective StudiesTreatment OutcomeTomography, Optical Coherence

Stichwörter der Autor:innen

Anti-VEGFFaricimabNeovascular age-related macular degenerationOCTSwitch

Substanzen

RanibizumabAngiogenesis InhibitorsVascular Endothelial Growth Factor AfaricimabAntibodies, Bispecific

Autor:innen und Institutionen

  • The Retina Service of Wills Eye Hospital, Wills Eye Physicians - Mid Atlantic Retina, Philadelphia, Pennsylvania.
  • Sidney Kimmel Medical College at Thomas Jefferson University, Department of Medicine, Philadelphia, Pennsylvania.
  • The Retina Service of Wills Eye Hospital, Wills Eye Physicians - Mid Atlantic Retina, Philadelphia, Pennsylvania. Electronic address: achiang@midatlanticretina.com.

Zitieren

APA

Pandit, S. A., Momenaei, B., Wakabayashi, T., Mansour, H. A., Vemula, S., Durrani, A. F., Pashaee, B., Kazan, A. S., Ho, A. C., Klufas, M., Regillo, C., Yonekawa, Y., Hsu, J., Kuriyan, A., & Chiang, A. (2024). Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration. Ophthalmology Retina, 8(4), 360-366. https://doi.org/10.1016/j.oret.2023.10.018

Vancouver

Pandit SA, Momenaei B, Wakabayashi T, Mansour HA, Vemula S, Durrani AF, et al. Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 2024;8(4):360-366. doi:10.1016/j.oret.2023.10.018

BibTeX
@article{Pandit2024,
  author = {Pandit, Saagar A and Momenaei, Bita and Wakabayashi, Taku and Mansour, Hana A and Vemula, Sudheshna and Durrani, Asad F and Pashaee, Bahram and Kazan, Adina S and Ho, Allen C and Klufas, Michael and Regillo, Carl and Yonekawa, Yoshihiro and Hsu, Jason and Kuriyan, Ajay and Chiang, Allen},
  title = {Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration},
  journal = {Ophthalmology Retina},
  year = {2024},
  volume = {8},
  number = {4},
  pages = {360--366},
  doi = {10.1016/j.oret.2023.10.018}
}
Kostenlos starten →